Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Personalized Cancer Treatment”

315 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 315 results

Not applicableEnded earlyNCT05082701
What this trial is testing

Sentinel™ Trial: A Prospective Study Evaluating the Performance and Clinical Benefit of Personalized ctDNA-based MRD Testing to Detect Recurrence and Monitor Treatment Response in Patients With Solid Tumors

Who this might be right for
Cancer
Strata Oncology 295
Not applicableUnknownNCT04079270
What this trial is testing

The Breast Cancer Personalized Nutrition Study

Who this might be right for
Breast Cancer
Sheba Medical Center 200
Not applicableNot Yet RecruitingNCT07391007
What this trial is testing

Integrated Clinical-molecular Risk Stratification to Early Recurrence in Colorectal Liver Metastases

Who this might be right for
Colorectal Liver Metastases
Fudan University 200
Large-scale testing (Phase 3)Active Not RecruitingNCT04055493
What this trial is testing

Adj. Marker-adjusted Personalized Therapy Comparing ET+Ribociclib vs Chemotherapy in Intermediate Risk, HR+/HER2- EBC

Who this might be right for
Breast Cancer Female
Women's Cancer Study Group GmbH 1,684
Not applicableUnknownNCT03908671
What this trial is testing

Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Esophageal Cancer and Non-small Cell Lung Cancer

Who this might be right for
Esophageal CancerNon Small Cell Lung Cancer
Stemirna Therapeutics 24
Not applicableNot Yet RecruitingNCT07406126
What this trial is testing

Yttrium-90 Radioembolization Neoadjuvant Therapy With Immune Marker Profiling and Dosimetry for Potentially Resectable Patients With Colorectal Liver Metastases

Who this might be right for
Colorectal Liver Metastases (CRCLM)Unresectable Colorectal Liver Metastases
Fernando Gómez Muñoz 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07406789
What this trial is testing

Phase II, Prospective, Randomized, Proof-of-concept Study to Evaluate the Effects of a Personalized Dietary Intervention in Women With Advanced Gynecologic or Breast Tumors Treated With Antibody-Drug Conjugates (ADCs).

Who this might be right for
Gynecologic CancersAdvanced Breast Cancer
TNC Nutrición Terapéutica S.L. 100
Testing effectiveness (Phase 2)Looking for participantsNCT06977074
What this trial is testing

PROPHET Study: ctDNA-Guided Personalized Induction Immunochemotherapy for NSCLC

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Sun Yat-sen University 83
Not applicableLooking for participantsNCT06751914
What this trial is testing

Neoantigen-based Peptide Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line Treatment

Who this might be right for
Colorectal Cancer (CRC)
The First Affiliated Hospital of Nanchang University 10
Not applicableStudy completedNCT01930435
What this trial is testing

Study of Personalized Sterile Humidification Device for Mucositis in Head and Neck Cancer Patients

Who this might be right for
Head and Neck Cancer
University of California, San Francisco 20
Early research (Phase 1)Looking for participantsNCT04846309
What this trial is testing

Hypoxia Imaging for Esophageal Cancer to Guide Personalized Radiation Therapy

Who this might be right for
Esophageal Cancer
University of Utah 16
Early research (Phase 1)Looking for participantsNCT04147078
What this trial is testing

Personalized DC Vaccine for Postoperative Cancer

Who this might be right for
Gastric CancerHepatocellular CarcinomaNon-Small-Cell Lung Cancer+1 more
Sichuan University 80
Not applicableLooking for participantsNCT07315633
What this trial is testing

An Innovative CFD-based Dosimetry and Pre-treatment Planning Platform to Support Personalized Transarterial Therapies for Liver Cancer

Who this might be right for
Hepatocellular Carcinoma (HCC)Liver Cancer, AdultLiver Cancer
University Hospital, Ghent 80
Not applicableLooking for participantsNCT07004582
What this trial is testing

Lab Research Using Mini-tumors to Study Prostate Cancer Treatments

Who this might be right for
Prostate CancerProstate Cancer Metastatic DiseaseProstate Cancer Recurrent+1 more
Maastricht Radiation Oncology 600
Testing effectiveness (Phase 2)Ended earlyNCT00509366
What this trial is testing

Study Using a Genomic Predictor of Platinum Resistance to Guide Therapy in Stage IIIB/IV Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Duke University 101
Early research (Phase 1)Study completedNCT02808416
What this trial is testing

Personalized Cellular Vaccine for Brain Metastases (PERCELLVAC3)

Who this might be right for
Brain CancerNeoplasm Metastases
Guangdong 999 Brain Hospital 10
Very early researchWithdrawnNCT03671720
What this trial is testing

Personalized Vaccine Generated by Autologous Dendritic Cells Pulsed With Autologous Whole Tumor Cell Lysate Treat Advanced Solid Tumor Patients With High Tumor Mutation Burden

Who this might be right for
Advanced CancerMetastatic Cancer
Capital Medical University
Not applicableActive Not RecruitingNCT06230016
What this trial is testing

Adhesion of Children and Adolescents Treated for Cancer to Personalized Support in Adapted Physical Activity Program

Who this might be right for
Childhood CancerAdapted Physical Activity
University Hospital, Grenoble 38
Testing effectiveness (Phase 2)Ended earlyNCT03480152
What this trial is testing

Messenger RNA (mRNA)-Based, Personalized Cancer Vaccine Against Neoantigens Expressed by the Autologous Cancer

Who this might be right for
MelanomaColon CancerGastrointestinal Cancer+2 more
National Cancer Institute (NCI) 5
Testing effectiveness (Phase 2)Looking for participantsNCT06311214
What this trial is testing

Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Malignant Solid Neoplasm
National Cancer Institute (NCI) 500
Next Page